Close Menu

NEW YORK (GenomeWeb) – Emory University's School of Medicine and global testing firm Eurofins Scientific today announced they have entered into an agreement whereby Eurofins will acquire a controlling interest in the Emory Genetics Laboratory (EGL).

EGL is a part of the Department of Human Genetics and provides testing services for hospitals and other institutional clients. It specializes in next-generation sequencing testing, especially for rare genetic disorders, the university said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Los Angeles Times reports that a case of the novel coronavirus making people ill in China has been reported in the US. 

A bipartisan group of senators has introduced a bill seeking increased funding for certain fields, including synthetic biology, ScienceInsider reports. 

Discover magazine writes that paleoproteomics is increasing being used in archaeology, paleoanthropology, and paleontology, including a recent study of a 6,000-year-old ring. 

In Nucleic Acids Research this week: mutagenic effects of ultraviolet "A" light, post-transcription effects of synonymous mutations, and more.